Behind EUD

Acta Oncologica

Volumn 47, Issue 5, 2008, Pages 971-972

  Wang, Jian Z ^a,b   Mayr, Nina A ^a   Yuh, William T C ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CLONOGENESIS; EXTERNAL BEAM RADIOTHERAPY; LETTER; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE;

BRACHYTHERAPY; DOSE FRACTIONATION; HUMANS; MODELS, THEORETICAL; NEOPLASMS; RADIOBIOLOGY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL;

EID: 45849115149     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860701885440     Document Type: Letter

References (14)

1. Niemierko A. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med Phys 1997;24:103-10.
2. Niemierko A. A generalized concept of equivalent uniform dose (EUD). Med Phys 1999;26:1100 (Abstract).
3. Wu Q, Mohan R, Niemierko A, Schmidt-Ullrich R. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys 2002;52:224-35.
4. Wang JZ, Li XA. Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose. Med Phys 2003;30:34-40.
5. Wang JZ, Li XA, D'Souza WD, Stewart RD. Impact of prolonged fraction delivery times on tumor control: A note of caution for intensity-modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys 2003;57:543-52.
6. Li XA, Wang JZ, Stewart RD, DiBiase SJ. Dose escalation in permanent brachytherapy for prostate cancer: Dosimetric and biological considerations. Phys Med Biol 2003;48:2753-65.
7. Wang JZ, Guerrero M, Li XA. How low is the α/β ratio for prostate cancer? Int J Radiat Oncol Biol Phys 2003;55:194-203.
8. Wang JZ, Li XA, Yu CX, DiBiase SJ. The low α/β ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us? Int J Radiat Oncol Biol Phys 2003;57:1101-8.
9. Levegrun S, Jackson A, Zelefsky MJ, Skwarchuk MW, Venkatraman ES, Schlegel W, et al. Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: Pitfalls in deducing radiobiologic parameters for tumors from clinical data. Int J Radiat Oncol Biol Phys 2001;51:1064-80.
10. Joiner MC, Bentzen SM. Time-dose relationships: The linear-quadratic approach. In: Steel GG editor. Basic clinical radiobiology. 2002. p 120-133.
11. Courdi A. Fractionation sensitivity and equivalent doses. Commenting on the editorial by Glimelius. Acta Oncol 2007;46:395-6; author reply 396.
12. Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 1985;8:S13-9.
13. Deasy JO. Comments on the use of the Lyman-Kutcher-Burman model to describe tissue response to nonuniform irradiation. Int J Radiat Oncol Biol Phys 2000;47:1458-60.
14. Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol Biol Phys 1989;16:1623-30.